FRANCHISE·WATCH·DESK

FILING · MN · 2026 FDD

SEROTONIN CENTER FACILITY FDD (Franchise Disclosure Document) — 2026

The FDD is the 23-item legal disclosure every U.S. franchisor must hand you at least 14 days before you sign or pay anything (FTC Franchise Rule, 16 CFR 436). SEROTONIN CENTER FACILITY's most recent FDD tracked here is the 2026 FDD, filed with the Minnesota Department of Commerce (public CARDS portal). Registration-state filings are public records, so you can read it free, with no sign-up.

Get the documentpublic record · PDF
Download from the Minnesota regulator (free) ↗

PUBLIC RECORD · FILED 2026 · SOURCE STATE MN

What the 2026 filing revealedextracted from the filing
ITEM 5Initial franchise fee$59,000
ITEM 6Ongoing royalty7.0% of gross sales
ITEM 7Total initial investment$905K–$1.8M
ITEM 3Disclosed litigation matters0
ITEM 19Earnings disclosure (FPR)Yes — financial performance representation made
ITEM 20Outlets (fiscal 2025)8 franchised at year end · 5 exits (exit rate 83.3%, fiscal 2025)
ITEM 21Franchisor financial statementsUnmodified (clean) opinion — Divine, Blalock, Martin & Sellari, LLC
Item 19 · how SEROTONIN CENTER FACILITY's earnings claim is built2026 FDD · page-cited

This filing makes an Item 19 earnings claim; we have not yet read how it is built. Open Item 19 and check which units it covers, which it leaves out, and whether it shows costs.

Item 21 · SEROTONIN CENTER FACILITY's own audited statements2026 FDD · page-cited

Divine, Blalock, Martin & Sellari, LLC gave an unmodified (clean) opinion on the statements in the 2026 FDD; revenue rose 1186% from FY2023 to FY2025 and it reported a net loss in FY2023 and FY2024.

Audit opinion

Unmodified (clean) opinion

Divine, Blalock, Martin & Sellari, LLC · p. 282

Revenue · FY2025

$3.8M

p. 285 · matched to statement

Net income · FY2025

$513K

p. 285 · matched to statement

Where FY2025 revenue came from

15% royalties

initial-fee share not extracted

  • Fiscal years covered: FY2023, FY2024, FY2025 (2026 FDD, statements from p. 285)
  • Statements are for: SEROTONIN ENTERPRISES, LLC
  • Parent / owner: not identified in the statements
Fiscal yearFY2023FY2024FY2025
Total revenue$296Kp. 285 · matched to statement$1.3Mp. 285 · matched to statement$3.8Mp. 285 · matched to statement
Royalty revenue$113Kp. 285 · matched to statement$254Kp. 285 · matched to statement$554Kp. 285 · matched to statement
Net income (loss)−$2.4Mp. 285 · matched to statement−$1.7Mp. 285 · matched to statement$513Kp. 285 · matched to statement
Equity (deficit) at year endnot extracted−$4.3Mp. 284−$3.8Mp. 284
Cash at year endnot extracted$82Kp. 284$13Kp. 284

How to read this: royalties recur as long as franchisees trade; initial and development fees arrive only when new franchises are sold. A franchisor whose revenue leans on initial fees is funding itself by selling territories, and that revenue stops when sales slow. Under ASC 606 most franchisors recognize initial fees over the agreement term, so the line understates the cash collected in a strong selling year. Ad-fund revenue, where reported, is included in total revenue as the statements present it.

Each figure links to its page in the filed PDF. “Matched to statement” means our extraction and a second, rule-based read of the statement page agree; “extracted · not cross-checked” means the statement page is a scanned image or could not be read as text. Figures we could not place on a consistent scale are withheld, not guessed. Spotted an error? Report a correction.

Every figure above was extracted by software from the 2026 SEROTONIN CENTER FACILITY FDD as filed (figures are not individually checked by a person) and links back to that document. Fields that could not be extracted are omitted; no figure here is estimated. Extraction errors are possible: the filing controls, and FDDs are reissued annually; verify against the current issuance before relying on any number. Spotted an error? Franchisors and owners can report it via the contact on our Terms page.

SEROTONIN CENTER FACILITY FDD questions, answered

Where can I download the SEROTONIN CENTER FACILITY FDD for free?

SEROTONIN CENTER FACILITY's 2026 Franchise Disclosure Document is a public record, filed with the Minnesota Department of Commerce (public CARDS portal). It can be downloaded free from the source link on this page — no broker form, no email signup required.

What year is SEROTONIN CENTER FACILITY's most recent FDD on file?

The most recent SEROTONIN CENTER FACILITY FDD tracked here is the 2026 FDD, filed with the Minnesota Department of Commerce (public CARDS portal). Franchisors must update their FDD annually; confirm you are reading the current issuance before signing.

Does SEROTONIN CENTER FACILITY's FDD disclose earnings (Item 19)?

Yes — SEROTONIN CENTER FACILITY makes a financial performance representation in Item 19 of its 2026 FDD. Read the basis fine print: franchisors choose which units and metrics to include.

What does SEROTONIN CENTER FACILITY's FDD Item 20 show?

In fiscal 2025, SEROTONIN CENTER FACILITY ended with 8 franchised outlets; 5 of 6 open at the start of the year left the system (exit rate 83.3%, fiscal 2025) through terminations, non-renewals, and "ceased operations — other reasons".

The SEROTONIN CENTER FACILITY validation checklist

questions built from this brand's own filings · read them all on the profile

Want this as a checklist you can take to the calls?

I'll email you the printable version, and tell you if SEROTONIN CENTER FACILITY’s numbers move — a new filing, a rising exit rate, a distress signal. Unsubscribe in one click.

Before you sign anythingfree · 30 min · no commission

A broker is usually paid by the franchisor to place you. I'm paid only by you, never by a franchisor you're considering — and the job is pressure-testing SEROTONIN CENTER FACILITY’s numbers, including talking you out of a bad deal.

Don Drummond, CPA — Virginia #43775 · what I charge

Book a free 30-minute call →